Table 3.

Kaplan and Meier Estimates for Relapse, LFS, and Survival Probabilities at 3 Years According to Cytogenetic Stratification

Relapse (SE)LFS (SE)Survival (SE)
AlloBMT Good 0.09 (0.04) 0.67 (0.06) 0.68 (0.06) 
 Standard 0.25 (0.02) 0.57 (0.02) 0.59 (0.02) 
 Poor 0.61 (0.09) 0.29 (0.07) 0.32 (0.07) 
 P .000001 .0005 .0002 
ABMT Standard 0.46 (0.02) 0.48 (0.02) 0.54 (0.02) 
 Poor 0.77 (0.07) 0.21 (0.06) 0.33 (0.08) 
 P .0002 .002 .02 
Relapse (SE)LFS (SE)Survival (SE)
AlloBMT Good 0.09 (0.04) 0.67 (0.06) 0.68 (0.06) 
 Standard 0.25 (0.02) 0.57 (0.02) 0.59 (0.02) 
 Poor 0.61 (0.09) 0.29 (0.07) 0.32 (0.07) 
 P .000001 .0005 .0002 
ABMT Standard 0.46 (0.02) 0.48 (0.02) 0.54 (0.02) 
 Poor 0.77 (0.07) 0.21 (0.06) 0.33 (0.08) 
 P .0002 .002 .02 

For AlloBMT, abn (16) and t(8; 21) were of good prognosis; t(15; 17), a diploid, a pseudodiploid, or a hyperdiploid karyotype of intermediate prognosis; and abn 11q, abn 5 and/or 7, or hypodiploidy of poor prognosis. In the ABMT patients, abn 5 and/or 7 and hypodiploidy were of poor prognosis; All other karyotypes were associated with a standard prognosis.

Abbreviations: LFS, leukemia-free survival; SE, standard error of the mean; AlloBMT, allogeneic bone marrow transplantation; ABMT, autologous bone marrow transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal